Capital Pulse#94 min read

Week of Mar 02-06, 2026

Healthcare stocks bifurcated: behavioral health and healthcare IT surged on earnings beats, while payers and dental cratered on regulatory shocks and geopolitical contagion.

Dental

TickerCompanyPriceWoWYTD
XRAYDENTSPLY SIRONA$12.74-11.5%+11.1%
NVSTEnvista Holdings$26.86-6.9%+23.0%
ALGNAlign Technology$174.00-5.7%+10.3%
HSICHenry Schein$77.60-4.0%+2.6%

All four dental names declined. DENTSPLY SIRONA (XRAY) was the worst performer on the entire watchlist at -11.5%, hit by a geopolitical-driven selloff that disproportionately affected small- and mid-cap names. Director Gregory Lucier bought ~50,000 shares at $14.03-14.24 — meaningful insider conviction. Align (ALGN) -5.7%, Envista (NVST) -6.9%, Henry Schein (HSIC) -4.0%. No company-specific catalysts; this was risk-off rotation out of medtech and dental supply.

Payers & Insurance

TickerCompanyPriceWoWYTD
ELVElevance Health$289.64-8.1%-17.4%
CIThe Cigna Group$271.63-5.5%-1.3%
HUMHumana$179.15-4.9%-30.0%
MOHMolina Healthcare$144.47-4.7%-17.0%
CVSCVS Health$77.92-2.5%-0.9%
CNCCentene$43.65-1.3%+6.0%
UNHUnitedHealth Group$286.48-0.6%-13.4%

Every payer name finished in the red. Elevance Health (ELV) -8.1% after CMS notified the company of planned intermediate sanctions that could freeze Medicare Advantage enrollment starting March 31. The cause: Elevance used flash drives instead of CMS-approved electronic methods for risk adjustment data for seven years. Contagion hit the entire managed care complex — Humana -4.9%, Cigna -5.5%, Molina -4.7%. Only UnitedHealth (-0.6%) held firm.

Hospital Systems & Providers

TickerCompanyPriceWoWYTD
ACHCAcadia Healthcare$25.62+10.2%+79.2%
SEMSelect Medical$16.25+9.8%+9.7%
UHSUniversal Health Services$192.65-5.2%-11.5%
DVADaVita$150.76-2.8%+32.6%
HCAHCA Healthcare$532.81+0.5%+14.4%
CYHCommunity Health Systems$3.35+0.3%+7.4%
THCTenet Healthcare$236.95+0.0%+19.1%

The strongest sector. Acadia Healthcare (ACHC) +10.2% on Q4 revenue of $821.5M beating forecasts. 29% short interest creates massive squeeze potential. Select Medical (SEM) +9.8% continues its quiet run. HCA +0.5%. Hospital operators benefit from volume growth and are insulated from the Medicare Advantage drama hitting payers.

Healthcare Services & Tech

TickerCompanyPriceWoWYTD
GDRXGoodRx$2.28+26.7%-16.8%
VEEVVeeva Systems$195.49+8.5%-12.5%
HIMSHims & Hers Health$15.74+8.5%-52.3%
AGLagilon health$0.60+6.8%-14.7%
PGNYProgyny$18.31+6.0%-28.6%
OSCROscar Health$13.84+5.1%-4.2%
LFSTLifeStance Health$6.93-3.4%-1.3%
PRVAPrivia Health$23.27-3.0%-1.3%
ALHCAlignment Healthcare$18.44-2.6%-6.6%
TDOCTeladoc Health$5.08-0.2%-27.4%

The biggest dispersion. GoodRx (GDRX) surged +26.7% on reports it's negotiating with the White House to join the TrumpRx platform. Veeva Systems (VEEV) +8.5% after crushing Q4 — revenue $836M (+16% YoY), EPS $2.06 beat $1.94 consensus. Hims & Hers +8.5%. On the other side, Teladoc flat, LifeStance -3.4%, Privia -3.0%.

Weekly Intelligence Debrief

Macro narrative, theme clusters, and hidden connections for the week of Mar 02-06, 2026.

Macro Patterns

  • 1XLV underperformed SPY by 3.2 percentage points — worst week for healthcare vs. market in 2026
  • 2Payer selloff driven by Elevance CMS sanctions — regulatory risk repricing across managed care
  • 3Healthcare IT (Veeva) proving revenue durability commands premium in volatile markets

Week Ahead

  • 1No healthcare earnings on watchlist this week
  • 2CPI data Wednesday — higher rates compress healthcare growth multiples
  • 3Elevance/CMS March 31 sanctions deadline approaching
  • 4Q1 earnings season starts mid-April: JNJ (Apr 14), Abbott (Apr 15), UNH (Apr 16)

Contrarian Signal

DENTSPLY SIRONA director bought 50,000 shares into the -11.5% decline. Insider buying during selloffs is one of the strongest contrarian signals in small-cap healthcare.

Regulatory Pulse

CMS notified Elevance Health of planned intermediate sanctions that could freeze Medicare Advantage enrollment starting March 31. The cause: using flash drives instead of CMS-approved electronic methods for risk adjustment data submission over seven years. Court decision expected by March 31. DOJ gender-affirming care subpoenas headed to Ninth Circuit.

Watchlist Signal

Healthcare Services & Tech outperformed XLV by +9.3%. Hospitals outperformed by +5.9%. Payers tracked XLV. Dental underperformed by -2.9%. Binary catalysts ahead: GoodRx/TrumpRx, Elevance/CMS March 31 deadline, Acadia short squeeze at 29%.

Data Point of the Week

XLV -4.1% vs SPY -0.9% — healthcare underperformed the broad market by 3.2 percentage points this week.

Get The Healthcare Edge in your inbox

Daily intelligence for dental professionals. Free, forever.

For informational purposes only. Data may be incomplete, delayed, or contain errors. Does not constitute investment, financial, legal, or clinical advice. Do not make business, staffing, acquisition, or patient care decisions based solely on this information. Verify all data independently before acting. Praxis AI assumes no liability for actions taken based on information presented here.